Nonfatal myocardial infarction is, by itself, an inappropriate end point in clinical trials in cardiology
- J. L. Fleiss
- , J. T. Bigger
- , M. McDermott
- , J. P. Miller
- , T. Moon
- , A. J. Moss
- , D. Oakes
- , L. M. Rolnitzky
- , T. M. Therneau
Research output: Contribution to journal › Editorial
23
Link opens in a new tab
Scopus
citations